Grants & Sponsorships

Welcome to the Medical Grants and Sponsorships website for Idorsia Pharmaceuticals Ltd. We thank you for considering Idorsia as a potential source to provide support for your proposed programs and activities. This website provides details to help in the preparation and submission of your funding request. We are proud to support the following types of programs that advance the educational objectives of the healthcare and patient community:

Educational Grant

Unrestricted funding to support an accredited or non-accredited activity developed and conducted by a third-party that is educational in nature, including classes, activities, programs, or events that involve the imparting of knowledge or skills used by healthcare practitioners. Note that non-accredited activities should still meet the same requirements as accredited activities. We invite you to submit funding requests for medical grants that provide legitimate education of healthcare professionals in our therapeutic area of interest: Insomnia.

Patient Advocacy Organization Grant

Funding for activities that advance the objectives of non-profit patient advocacy organizations. We invite you to submit funding requests for Patient Advocacy Organization grants in the disease areas of Insomnia. Note that patient advocacy organizations are not eligible for funding support at this time in the US.

Medical Sponsorship

An arrangement where Idorsia provides funds to an organization in return for enabling Idorsia to promote its company name to an audience or to maintain a booth, in accordance with local regulations. We invite you to submit medical sponsorship requests in our therapeutic area of interest: Insomnia.

How to Submit Medical Grants and Sponsorship Requests?

Requests for grant funding must be submitted to Idorsia via the Medical Grants and Sponsorship portal, at least 60 days prior to the scheduled program start date.  To begin your application in our Idorsia Medical Grants and Sponsorship portal, please create a login and password or enter your existing username and password. Upon completion of review, requestors will be notified of the Committee’s decision via email.